FealtySign in
Promise-keeping streak11 kept in a rowguidance & buyback

AMGEN INC

(AMGN)

CIK 318154 · SEC filings only

Not gradedDividend record
shown as history
company entity
48 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

48 declarations · 12 raised · 33 held · 0 cut

  1. INITIATED$2.5200/shperiod ended 2025-12-31Filing ↗
  2. HELD$2.2500/shperiod ended 2024-03-31Filing ↗
  3. RAISED$2.2500/shperiod ended 2023-12-12Filing ↗
  4. HELD$2.1300/shperiod ended 2023-10-31Filing ↗
  5. HELD$2.1300/shperiod ended 2023-07-31Filing ↗
  6. HELD$2.1300/shperiod ended 2023-03-31Filing ↗
  7. RAISED$2.1300/shperiod ended 2022-12-31Filing ↗
  8. HELD$1.9400/shperiod ended 2022-10-31Filing ↗
  9. HELD$1.9400/shperiod ended 2022-07-31Filing ↗
  10. HELD$1.9400/shperiod ended 2022-03-31Filing ↗
  11. RAISED$1.9400/shperiod ended 2021-12-31Filing ↗
  12. HELD$1.7600/shperiod ended 2021-10-31Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
A+Buyback record
grade
company entity
7 resolved promises

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Credibility timeline

PARTIAL · Feb 24, 2014KEPT · Feb 13, 2018KEPT · Feb 13, 2019KEPT · May 1, 2020KEPT · Nov 4, 2022KEPT · Oct 31, 2023KEPT · Feb 14, 2024
20142024
Timeline as a list
  • Feb 24, 2014PARTIALAmgen’s Board of Directors has authorized an increase to the Company’s stock repurchase program to a total amount of $10 billion
  • Feb 13, 2018KEPTapproved an increase in the remaining share repurchase authorization for an aggregate authorization of $5 billion
  • Feb 13, 2019KEPTapproved an increase in the remaining share repurchase authorization for an aggregate authorization of $5 billion
  • May 1, 2020KEPTThe Company’s Board of Directors authorized an additional $10 billion of share repurchases
  • Nov 4, 2022KEPTShare repurchases will be executed opportunistically resulting in an amount at the lower end of our previous guidance of $3 billion to $5 billion
  • Oct 31, 2023KEPTShare repurchases at the upper end of our previous guidance of $3.0 billion to $5.0 billion
  • Feb 14, 2024KEPTIn October 2021, the Board of Directors increased the amount authorized under our stock repurchase program by an additional $4.5 billion
7 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
AGuidance record
grade
company entity
16 resolved promises

Sector median (Life Sciences): B across 7 graded companies

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

11 of 27 guidance figures that were graded or dropped for basis could not be graded on the same basis (41%). Guidance marked “not judged” is in neither number.

Guidance typeSaidGradedDroppedOther
Revenue · basis not stated2911018
EPS · GAAP13508
EPS · non-GAAPcannot be graded2901118

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (29)

We show what was said — with its source filing — but never score it. The line under each statement says why.

  1. eps guidance fy · Nov 2, 2021
    On a non-GAAP basis, EPS in the range of $16.50 to $17.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · Aug 3, 2021
    EPS in the range of $16.00 to $17.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Apr 27, 2021
    On a non-GAAP basis, EPS in the range of $16.00 to $17.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Feb 2, 2021
    On a non-GAAP basis, EPS (1) in the range of $16.00 to $17.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Oct 28, 2020
    On a non-GAAP basis, EPS in the range of $15.80 to $16.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Jul 28, 2020
    revised to $15.10-$15.75 on a non-GAAP basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Apr 30, 2020
    On a non-GAAP basis, EPS in the range of $14.85 to $15.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Jan 30, 2020
    $14.85 - $15.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance fy · Jul 26, 2018
    On a non-GAAP basis, EPS in the range of $13.30 to $14.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · Feb 1, 2018
    $12.60-$13.70 on a non-GAAP basis
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · Jul 25, 2017
    On a non-GAAP basis, EPS in the range of $12.15 to $12.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Feb 2, 2017
    EPS in the range of $11.80 to $12.60
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Oct 27, 2016
    EPS in the range of $11.40 to $11.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Apr 28, 2016
    adjusted EPS in the range of $10.85 to $11.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Oct 28, 2015
    adjusted EPS in the range of $10.35 to $10.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · Oct 28, 2015
    adjusted EPS in the range of $9.95 to $10.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance fy · Apr 21, 2015
    adjusted EPS in the range of $9.35 to $9.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Oct 27, 2014
    adjusted EPS to be in the range of $8.45 to $8.55
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance fy · Apr 22, 2014
    adjusted EPS to be in the range of $7.90 to $8.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Jan 28, 2014
    adjusted EPS to be in the range of $7.90 to $8.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · Jul 30, 2013
    Adjusted EPS to be in the range of $7.30 to $7.45
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Jan 23, 2013
    adjusted EPS to be in the range of $6.85 to $7.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance fy · Jul 26, 2012
    adjusted EPS to be in the range of $6.20 to $6.35
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Jan 26, 2012
    Amgen expects 2012 adjusted EPS to be in the range of $5.90 to $6.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance fy · Oct 24, 2011
    The Company increased its guidance ranges for total revenue and adjusted EPS to $15.4 billion to $15.6 billion and $5.15 to $5.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. eps guidance fy · Apr 20, 2011
    Amgen continues to expect 2011 adjusted EPS to be in the range of $5.00 to $5.20
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance fy · Oct 25, 2010
    The Company reaffirmed both revenue and adjusted EPS guidance at slightly below $15.1 billion and towards lower end of $5.05 to $5.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. eps guidance fy · Apr 21, 2010
    The Company now expects revenues and adjusted EPS for 2010 to be towards the lower end of the current guidance ranges of $15.1 billion to $15.5 billion and $5.05 to $5.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. eps guidance fy · Oct 26, 2004
    The company increased full-year guidance for adjusted earnings per share to a range of $2.38 to $2.43
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (1) · 25 superseded

Open · revenue guidance fy

Total revenue guidance for 2004 was increased to a range of $10.3 to $10.6 billion

unresolved — no outcome on filereceipt (opens in a new tab)
Superseded · eps guidance fy

On a GAAP basis, EPS in the range of $9.11 to $10.71

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $21.7 billion to $22.3 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

EPS in the range of $10.45 to $11.31

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

2020 total revenues guidance reaffirmed at $25.0-$25.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

2020 total revenues guidance of $25.0 - $25.6

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

On a GAAP basis, EPS in the range of $10.65 to $11.45

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

The Company reaffirmed its total revenue guidance for 2011 to be in the range of $15.1 billion to $15.5 billion.

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

On a GAAP basis, EPS in the range of $12.12 to $13.17

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

EPS guidance of $11.18-$12.36 on a GAAP basis

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

2018 total revenues guidance of $21.8-$22.8 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $25.0 billion to $25.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues to be in the range of $17.8 billion to $18.2 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $25.8 billion to $26.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

EPS guidance of $10.85 - $11.65

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues to be in the range of $19.2 billion to $19.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $25.8 billion to $26.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $20.9 billion to $21.3 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $25.8 billion to $26.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

The Company now expects revenues and adjusted EPS for 2010 to be towards the lower end of the current guidance ranges of $15.1 billion to $15.5 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $22.2 billion to $22.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues to be in the range of $19.2 billion to $19.6 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total revenues in the range of $22.3 billion to $23.1 billion

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

EPS in the range of $8.84 to $9.90

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

The Company expects total revenue for 2012 to be in the range of $16.1 billion to $16.5 billion.

revised by a later guidancereceipt (opens in a new tab)
Superseded · eps guidance fy

EPS guidance revised to $10.73-$11.43 on a GAAP basis

revised by a later guidancereceipt (opens in a new tab)

Credibility timeline

ABOVE · Feb 19, 2015ABOVE · Feb 16, 2016ABOVE · Feb 14, 2017ABOVE · Feb 14, 2017IN LINE · Feb 13, 2018BELOW · Feb 13, 2018ABOVE · Feb 13, 2019IN LINE · Feb 13, 2019IN LINE · Feb 9, 2021ABOVE · Feb 9, 2021ABOVE · Feb 16, 2022IN LINE · Feb 16, 2022
20152022
Timeline as a list
  • Feb 19, 2015ABOVETotal revenues to be in the range of $19.8 billion to $20.0 billion
  • Feb 16, 2016ABOVETotal revenues in the range of $21.4 billion to $21.6 billion
  • Feb 14, 2017ABOVETotal revenues in the range of $22.6 billion to $22.8 billion
  • Feb 14, 2017ABOVEEPS in the range of $9.94 to $10.11
  • Feb 13, 2018IN LINETotal revenues in the range of $22.5 billion to $23.0 billion
  • Feb 13, 2018BELOWOn a GAAP basis, EPS in the range of $10.79 to $11.37
  • Feb 13, 2019ABOVETotal revenues in the range of $22.5 billion to $23.2 billion
  • Feb 13, 2019IN LINEOn a GAAP basis, EPS in the range of $11.83 to $12.62
  • Feb 9, 2021IN LINETotal revenues in the range of $25.1 billion to $25.5 billion
  • Feb 9, 2021ABOVEOn a GAAP basis, EPS in the range of $11.53 to $11.93
  • Feb 16, 2022ABOVEOn a GAAP basis, EPS in the range of $9.55 to $10.21
  • Feb 16, 2022IN LINETotal revenues in the range of $25.8 billion to $26.2 billion
16 resolved guidance promises · 29 not graded (no comparable reported figure) · resolver resolver-v5 · score score-v1. Every verdict links to its source filing. Full methodology →